John Ersson

Senior Associate, Stockholm

John Ersson is a Stockholm-based Senior Associate working with Roschier’s Private M&A practice, focusing on private M&A and private equity. He joined Roschier in 2017.

John Ersson’s experience includes advising:

  • KKR’s life science platform Gamma Biosciences in the USD 215 million sale of Astrea Bioseparations to Biotage;
  • Bonnier Ventures in their investment in diagnostics company Elypta;
  • Nordstjernan in its investment in audience engagement company Mentimeter.

Roschier (2017-)

Stockholm University, LL.M. (2017)

English, Swedish